. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Am J Ophthalmol. 2014 Nov 18;159(3):426–436.e2. doi: 10.1016/j.ajo.2014.11.022

Table 2.

Anatomic and functional treatment response after switching to every 8 weeks intravitreal aflibercept injections in recurrent or persistent neovascular age-related macular degeneration

	Median (IQR)	P value^*
Maximum retinal thickness (in microns) Baseline 6 months 1 year	355 (325-427) 269 (227-325) 248 (201-279)	<0.0001 <0.0001
ETDRS visual acuity (in logMAR) Baseline 6 months 1 year	0.40 (0.30-0.70) 0.40 (0.20-0.70) 0.40 (0.20-0.90)	0.2559 0.1081

Wilcoxon signed test

ETDRS, Early Treatment Diabetic Retinopathy Study; logMAR, logarithm of the minimum angle of resolution